Beth-El公司制造出便携式负压隔离舱

一种可折叠的负压隔离舱正在接受测试，以评估它如何在急诊科帮助进行挽救生命的手术程序。

哈佛教学医院和Brigham与妇女医院的国际急诊医学与健康医学(IEMH)的研究人员开展了这项测试。研究人员使用整合计算机系统和人体模型来模拟各种各样的医学程序，评估在舱内的行为如何影响患者与医疗团队的安全性。这种舱在医院的环境之内20分钟即可建立，提供完全的隔离环境，能够被安放在任何需要的地方。

“我们十分高兴，能够有机会参与到这样一个在医院环境内创造全新的隔离环境的试验中”。IEMH主任Mark Davis医生如此评论说。该项测试在Stratus中心进行，这是Brigham与妇女医院的急诊室模拟环境。

这套隔离系统叫做IsoArk，是由Beth-El Zikhron Yaaqov工业公司(Yaaqov, Israel)制造的。该公司是化学、生物、放射保护技术的提供者。Beth El公司在美国的市场代表、Collective保护工程公司商业发展部副总裁Dan Collier指出。“IsoArk为医院提供了价廉物美的选择，可以替代为患者隔离基础设施所花费的巨大投资。”
 
Portable Isolation System for ED
 
A collapsible, negative-pressure isolation chamber is being tested to determine how it might aid life-saving operational procedures in the emergency department.

The test is being conducted by investigators at the Institute for International Emergency Medicine and Health (IEMH) at Harvard’s teaching hospital, Brigham and Women’s (Boston, MA, USA). The investigators are using integrated computer systems and manikins to simulate a wide array of medical procedures and to evaluate how their performance inside the chamber affects patient and team safety. The chamber can be erected within 20 minutes within a hospital to provide a full isolation solution and then be stored away when not needed.

“We are excited to have the opportunity to participate in an entirely new approach to the creation of isolation capabilities within hospitals, said Mark Davis, M.D., director of the IEMH. The test is being conducted in the Stratus Center, an emergency room simulation facility at Brigham and Women’s Hospital.

The isolation system, called IsoArk, is manufactured by Beth-El Zikhron Yaaqov Industries (Yaaqov, Israel). The company is a supplier of chemical, biologic, and radiologic protection technology. “The IsoArk gives hospitals a cost-effective alternative to the huge investments in infrastructure spent on patient isolation,” noted Dan Collier, vice president, business development, Collective Protection Engineering, Inc. (Halethorpe, MD, USA), Beth El’s marketing representative in the United States.